Omega Healthcare Investors Files 8-K

Ticker: OHI · Form: 8-K · Filed: Mar 12, 2024 · CIK: 888491

Omega Healthcare Investors Inc 8-K Filing Summary
FieldDetail
CompanyOmega Healthcare Investors Inc (OHI)
Form Type8-K
Filed DateMar 12, 2024
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, disclosure

Related Tickers: OHI

TL;DR

OHI filed an 8-K on 3/12. Details to follow.

AI Summary

Omega Healthcare Investors, Inc. filed an 8-K on March 12, 2024, reporting other events and financial statements/exhibits. The filing does not contain specific financial figures or details about the 'other events' in the provided text.

Why It Matters

This filing indicates Omega Healthcare Investors, Inc. is providing updates or disclosures to the SEC, which could contain important information for investors.

Risk Assessment

Risk Level: low — The filing is a standard disclosure and does not inherently present new risks based on the provided text.

Key Players & Entities

  • Omega Healthcare Investors, Inc. (company) — Registrant
  • March 12, 2024 (date) — Filing Date

FAQ

What specific 'Other Events' are being reported in this 8-K filing?

The provided text of the 8-K filing does not specify the details of the 'Other Events' being reported.

Are there any financial statements or exhibits included with this filing?

Yes, the filing is categorized under 'Financial Statements and Exhibits', indicating their inclusion, though the content is not detailed in the provided text.

What is the principal executive office address for Omega Healthcare Investors, Inc.?

The principal executive office is located at 303 International Circle, Suite 200, Hunt Valley, Maryland 21030.

What is the telephone number for Omega Healthcare Investors, Inc.?

The registrant's telephone number is (410) 427-1700.

What is the SIC code for Omega Healthcare Investors, Inc.?

The Standard Industrial Classification (SIC) code for Omega Healthcare Investors, Inc. is 6798, which corresponds to Real Estate Investment Trusts.

Filing Stats: 653 words · 3 min read · ~2 pages · Grade level 9.6 · Accepted 2024-03-12 16:49:51

Filing Documents

01 Other Events

Item 8.01 Other Events. On February 28, 2024, the Circuit Court for Baltimore City (the "Court") issued an order (the "Preliminary Approval Order") granting preliminary approval to a proposed settlement of certain shareholder derivative actions previously disclosed by Omega Healthcare Investors, Inc. (the "Company"). The proposed settlement was entered into, subject to the Court's approval, in accordance with a stipulation of settlement, dated as of February 22, 2024 (the "Stipulation of Settlement"), by and among plaintiffs Stourbridge Investments LLC, Phillip Swan, Tom Bradley, and Sarah Smith, the Company as a nominal defendant, and the named defendants in the shareholder derivative actions titled (i) Swan v. Pickett, et al., Case No. 24-C-19-000573 (Baltimore, Md. Cir. Ct.); (ii) Bradley, et al. v. Callen et al., Case No. 24-C-19-000972 (Baltimore, Md. Cir. Ct.); and (iii) Stourbridge Investments LLC v. Callen, et al., Case No. 1:18-cv-07638 (S.D.N.Y.). The Court has scheduled a hearing on May 21, 2024, at 2:00 p.m. Eastern Time, to determine whether it should issue an order for final approval of the proposed settlement. On March 12, 2024, the Company posted copies of the (1) Notice of Proposed Settlement and of Settlement Hearing (the "Notice"), which contains further information about the proposed settlement and the hearing, and (2) Stipulation of Settlement, to the Investors section of the Company's website under "Governance." As required by the Preliminary Approval Order, the Company is filing the Stipulation of Settlement, with exhibits thereto, and the Notice with this Current Report on Form 8-K, copies of which are attached hereto as Exhibits 99.1 and 99.2, respectively, and which are incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibits are being filed herewith: No. Description 99.1 Stipulation of Settlement, dated February 22, 2024 99.2 Notice of Proposed Settlement and of Settlement Hearing, dated February 28, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OMEGA HEALTHCARE INVESTORS, INC. Dated: March 12, 2024 By: /s/ Gail D. Makode Gail D. Makode Chief Legal Officer, General Counsel and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.